Valeant Pharmaceuticals Rallying On Job Cuts (VRX)
Valeant Pharmaceuticals International (NYSE: VRX) is rallying more than 3% this morning.
This morning, Valeant Pharmaceuticals and Biovail (NYSE: BVF) announced it would be cutting more than 25% of the combined workforce between the two companies.
In June, Biovail announced it would be purchasing Valeant Pharmaceuticals.
Shares of VRX are gaining $2.17 to trade at $62.15.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.